| Followers | 35 |
| Posts | 1912 |
| Boards Moderated | 0 |
| Alias Born | 11/05/2020 |
Wednesday, March 16, 2022 4:04:28 PM
That's the problem.
When you start putting on an act, it starts getting silly.
Being real goes a long way... and it really isn't hard to be humble and open when writing PR's.
Trying to "fool" people adds an unsavory characteristic to an already unsavory situation.
Instead of putting a PR about the upcoming payments for March 17th... he addresses requests about putting out a list of patents that they were granted.
Who would be asking that versus asking about the possible default?
Like you said, desperation seems to be what it looks like.
When you start putting on an act, it starts getting silly.
Being real goes a long way... and it really isn't hard to be humble and open when writing PR's.
Trying to "fool" people adds an unsavory characteristic to an already unsavory situation.
Instead of putting a PR about the upcoming payments for March 17th... he addresses requests about putting out a list of patents that they were granted.
Who would be asking that versus asking about the possible default?
Like you said, desperation seems to be what it looks like.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
